Portfolio     Aphelion Capital Aphelion Capital makes public and private investments in the Medical Technology Industry. Aphelion leverages its substantial medical technology knowledge and deep networks to enhance returns for both the fund and the entrepreneurs in whom the fund invests. Aphelion's managers have extensive experience investing in medical technology companies across both the public and private equity markets. They bring a wealth of expertise and an impressive network of contacts and support to the companies and managers in whom they invest. Aphelion Capital invests in medical technology companies across all stages and therapeutic areas, but strongly prefers investments in companies with low capital requirements and short time lines to market. The Fund is generally a long term investor in companies that we believe have superior products and strong management teams.     Azure Capital Partners Azure Capital Partners is a venture capital firm with over $650 million under management, headquartered in San Francisco, California. Their goal is to identify, invest in and help build early stage information technology companies that are at the forefront of a transformative opportunity for growth. Their partners have a long track record of identifying and helping to build some of the most successful companies in communications, consumer, enterprise and Internet technology segments. The Azure team is recognized for industry thought leadership and a unique professional investment approach to venture investing. Their proven methodology and primary research enable us to identify young companies in attractive markets whose business models provide sustainable competitive advantage.     California Technology Ventures California Technology Ventures LLC (CTV) is a venture capital fund that makes direct investments in technology and life science companies. CTV has built a strong reputation for its entrepreneurial approach to investing and working with companies. They believe in guiding entrepreneurs through the strategic, operational, and management decisions critical to a company’s success, in addition to leveraging their resources and people to achieve category leadership.  CTV participates in seed/start-up companies, first and second round investments, and later stage investments around the world.   CMEA Capital CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments.  They were founded in 1989 and maintain offices in San Francisco and Menlo Park. They invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies.  Their partners and associates have extensive science, engineering, and operational backgrounds, which provides them the confidence to look beyond today's technology.     CSV Capital Partners Established in 2004, CSV Capital Partners focuses on investing in and helping early-stage and emerging Chinese companies quickly become successful. CSV aims at investing in promising young companies and then introducing and leveraging them into the global markets through the experiences and contacts of our team. CSV is open to investing in a wide range of industry sectors including the Internet, outsourced services, IC design, wireless, traditional media, energy/environmental, consumer goods/retailing, and the life sciences.  CSV's partners combine extensive private equity, operating and China market experiences to assist entrepreneurs in creating industry-leading companies. Headquartered in Shanghai, CSV offers access to high quality partners in Asia and the United States and an extensive network of resources to support its portfolio companies. CSV has a strategic relationship with US-based Babson Capital Management LLC (www.babsoncapital.com).      DFJ Mercury DFJ Mercury is a seed and early-stage venture capital firm. Headquartered in Houston, Texas, DFJ Mercury invests in compelling and novel start-up opportunities in information technology, advanced materials and bioscience. DFJ Mercury seeks to partner with extraordinary entrepreneurs to build globally competitive businesses, focusing on investments in the midcontinent. Our team has broad experience and relationships with tech transfer offices and regional technology incubators, and appreciates hard science with solid intellectual property. Our firm has a particular focus on university spin-outs and incubation, often investing prior to a business plan or management team being formed. Since inception in 2005, DFJ Mercury has been one of the most active start-up and seed-stage investors in the midcontinent, has consistently rated as a top VC firm for entrepreneurs by Entrepreneur Magazine and TheFunded.com, and has become a "go-to" venture firm for entrepreneurs at the earliest stages of idea generation, company formation, and market execution. DFJ Mercury is a partner in the DFJ Global Network of venture funds   HealthCap HealthCap is a family of multi stage venture capital funds, investing internationally in life sciences, with the Odlander Fredrikson Group as their exclusive investments advisor. With committed capital exceeding SEK 7 bn, HealthCap is the largest specialized provider of venture capital within life sciences in the Nordic countries and one of the largest independent actors in the sector in Europe.     Innovations Kapital Innovations Kapital is a leading independent early stage venture capital firm for innovative growth companies in the Nordic region.  InnovationsKapital was founded in 1994, on the initiative of Chalmers University of Technology, in order to invest in start-up and early-stage high-tech companies. Their primary focuses are Information & Communications Technology (ICT) and Healthcare & Life Sciences companies and, since 1994, have made over 60 investments in those sectors.  InnovationsKapital Nordic Advisors AB is an independent management company and currently advises four venture funds aggregating EUR 317 million in committed capital. The capital is provided by highly reputable Swedish and international investors. They invest in start-up, early-stage, or early expansion stage companies, in the Nordic region (Sweden, Denmark, Finland & Norway).     Psilos Group Managers Psilos Group Managers LLC ("Psilos") is a venture capital firm focused on providing growth capital to companies operating in the healthcare economy. The firm believes that successful healthcare innovation must reduce cost, improve quality and align incentives across payers, providers and patients. Founded in 1998, Psilos has $577 million under management and invests across three core healthcare sectors: healthcare services, healthcare information technology and medical technology. Prior funds managed by Psilos have invested in portfolio companies such as ActiveHealth, AngioScore, Click4Care, Definity Health, Extend Health and OmniGuide, among many others, which have played, and continue to play, key roles in the transformation of the U.S. healthcare industry. Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico. Their team has a multi-disciplinary background and has participated in over 70 healthcare private equity transactions.     Home | About Us | Team | Portfolio | News | Contact Us © 2009 Jacobs Capital Group LLC. All Rights Reserved.